I have created a publication-quality, double-sided printable clinical reference document titled **7oh-clinical-intake-protocol.pdf** inside your Studio panel.  
This protocol compiles essential pharmacological context regarding the high potency of 7-hydroxymitragynine 1, 2 and outlines a structured, five-step intake algorithm to risk-stratify patients presenting with physical dependence 3, 4\. It also features standard clinician screening questions, a comprehensive six-stage clinical withdrawal timeline 5, and detailed dosing guidance for standard buprenorphine induction versus low-dose buprenorphine microinduction (tapered cross-over) 5-8.  
Here are a few ways we can refine this protocol to better fit your clinic's specific needs:

* **Modify buprenorphine dosing increments:** Adjust the Day 1–5 sublingual or transdermal titration schedule to match your local clinical formulary.  
* **Add customized intake fields:** Incorporate blank text blocks for patient vitals, COWS tracking rows, or signature lines directly onto the document.  
* **Expand treatment pathways:** Detail specialized secondary protocols for co-occurring dependencies (such as nicotine pouch or sedative co-exposures) 9\.

Let me know if you would like me to regenerate this file with any of these modifications\!  
📋 If you are preparing for the upcoming regulatory transition, we could also draft a matching clinical letter to send to local emergency departments and urgent care centers to raise awareness about these 7-OH withdrawal presentations.